Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for ATEC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 -19.53M
March 31, 2026 -1.774M
December 31, 2025 0.206M
September 30, 2025 -1.313M
June 30, 2025 0.366M
March 31, 2025 30.76M
December 31, 2024 50.64M
September 30, 2024 6.694M
June 30, 2024 3.242M
March 31, 2024 -4.37M
December 31, 2023 151.57M
September 30, 2023 60.32M
June 30, 2023 77.91M
March 31, 2023 67.11M
December 31, 2022 1.013M
September 30, 2022 29.44M
June 30, 2022 -1.926M
March 31, 2022 2.697M
December 31, 2021 -0.487M
September 30, 2021 183.68M
June 30, 2021 -2.007M
March 31, 2021 130.78M
December 31, 2020 109.82M
September 30, 2020 -0.09M
June 30, 2020 21.14M
Date Value
March 31, 2020 -0.039M
December 31, 2019 0.964M
September 30, 2019 55.44M
June 30, 2019 11.48M
March 31, 2019 -3.702M
December 31, 2018 6.47M
September 30, 2018 -0.129M
June 30, 2018 2.961M
March 31, 2018 44.58M
December 31, 2017 7.801M
September 30, 2017 -1.205M
June 30, 2017 -2.532M
March 31, 2017 13.76M
December 31, 2016 4.53M
September 30, 2016 -42.17M
June 30, 2016 -4.218M
March 31, 2016 -1.537M
December 31, 2015 0.017M
September 30, 2015 0.809M
June 30, 2015 -3.652M
March 31, 2015 -3.706M
December 31, 2014 3.677M
September 30, 2014 -0.431M
June 30, 2014 7.176M
March 31, 2014 20.31M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Artivion, Inc. 152.39M
CONMED Corp. -46.23M
Integra LifeSciences Holdings Corp. -0.818M
Teleflex, Inc. -82.00M
Globus Medical, Inc. -134.50M